BEUDAMED
    FDA Adverse Event Death Summary report: N

    DUROLANE 60 MG/ 3 ML SYR

    MDR report key: 22932149 · Received September 2, 2025

    Report

    Report Number
    MW5175432
    Event Type
    Death
    Date Received
    September 2, 2025
    Date of Event
    August 25, 2025
    Report Date
    August 26, 2025
    Manufacturer
    BIOVENTUS LLC
    Product Code
    MOZ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    UNKNOWN
    Health Professional
    N

    Narratives

    Description of Event or Problem · 0

    (B)(6) DOCTOR OFFICE REPORTED PASSED AWAY (B)(6) 2025. DUROLANE 60 MG/ 3 ML = 1 SYRINGE. STARTED INJECTION (B)(6) 2025. FREQ: INJECT CONTENT OF ONE SYRINGE INTRA-ARTICULARLY INTO EACH KNEE ONCE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2214460 DUROLANE 60 MG/ 3 ML SYR ACID, HYALURONIC, INTRAARTICULAR MOZ BIOVENTUS LLC 23175

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Female Death ALPRAZOLAM TAB 0.25MG. | ATORVASTATIN TAB 80MG. | BUMETANIDE TAB 0.5MG. | CLONIDINE TAB 0.1MG. | ELIQUIS TAB 2.5MG. | FAMOTIDINE.| FARXIGA TAB 10MG. | FUROSEMIDE TAB 40MG .| GABAPENTIN CAP 100MG. | LEVOTHYROXIN TAB 50MCG.